Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Vivancos MJ, Gómez-Ayerbe C, Moreno S.

    Highlights in HIV, 2016.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 30 Suppl 1: 13-15.

  • Geretti AM, Loutfy M, D'Arminio Monforte A, Latysheva I, Pérez Elías MJ, Rymer J, Boffito M.

    Out of focus: tailoring the cascade of care to the needs of women living with HIV.

    HIV MEDICINE . 18 Suppl 2: 3-17. Nº de citas: 9

    [doi:10.1111/hiv.12533]

  • Navarro M, Monge-Maíllo B, Flores-Chavez MD, López-Vélez R.

    Hunting hidden parasites: Trypanosoma cruzi.

    LANCET . 390(10096): 724-726. Nº de citas: 15

    [doi:10.1016/S0140-6736(17)31536-2]

  • Berenguer J, Rodríguez-Castellano E, Carrero A, Von Wichmann MA, Montero M, Galindo MJ, Mallolas J, Crespo M, Téllez MJ, Quereda C, Sanz J, Barros C, Tural C, Santos I, Pulido F, Guardiola JM, Rubio R, Ortega E, Montes ML, Jusdado JJ, Gaspar G, Esteban H, Bellón JM, González-García J.

    Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.

    HEPATOLOGY . 66(2): 344-356. Nº de citas: 49

    [doi:10.1002/hep.29071]

  • Gudiol C, Royo-Cebrecos C, Abdala E, Akova M, Álvarez R, Maestro-de la Calle G, Cano A, Cervera C, Clemente WT, Martín-Dávila P, Freifeld A, Gómez L, Gottlieb T, Gurguí M, Herrera F, Manzur A, Maschmeyer G, Meije Y, Montejo M, Peghin M, Rodríguez-Baño J, Ruiz-Camps I, Sukiennik TC, Tebe C, Carratalà J, BICAR Study Group.

    Efficacy of ß-Lactam/ß-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-ß-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . 61(8): . Nº de citas: 45

    [doi:10.1128/AAC.00164-17]

  • Poveda E, Hernández-Quero J, Pérez-Elías MJ, Ribas MA, Martínez-Madrid OJ, Flores J, Navarro J, Gutiérrez F, García-Deltoro M, Imaz A, Ocampo A, Artero A, Blanco F, Bernal E, Pasquau J, Mínguez-Gallego C, Pérez N, Aiestaran A, García F, Paredes R.

    Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.

    HIV MEDICINE . 18(7): 482-489. Nº de citas: 1

    [doi:10.1111/hiv.12479]

  • Henriquez-Camacho C, Villafuerte-Gutierrez P, Pérez-Molina JA, Losa J, Gotuzzo E, Cheyne N.

    Opt-out screening strategy for HIV infection among patients attending emergency departments: systematic review and meta-analysis.

    HIV MEDICINE . 18(6): 419-429. Nº de citas: 35

    [doi:10.1111/hiv.12474]

  • Lora-Tamayo J, Senneville É, Ribera A, Bernard L, Dupon M, Zeller V, Li HK, Arvieux C, Clauss M, Uçkay I, Vigante D, Ferry T, Iribarren JA, Peel TN, Sendi P, Miksic NG, Rodríguez-Pardo D, Del Toro MD, Fernández-Sampedro M, Dapunt U, Huotari K, Davis JS, Palomino J, Neut D, Clark BM, Gottlieb T, Trebše R, Soriano A, Bahamonde A, Guío L, Rico A, Salles MJ, Pais MJ, Benito N, Riera M, Gómez L, Aboltins CA, Esteban J, Horcajada JP, O'Connell K, Ferrari M, Skaliczki G, San Juan R, Cobo J, Sánchez-Somolinos M, Ramos A, Giannitsioti E, Jover-Sáenz A, Baraia-Etxaburu JM, Barbero JM, Choong PF, Asseray N, Ansart S, Le Moal G, Zimmerli W, Ariza J, and the Group of Investigators for Streptococcal Prosthetic Joint Infection..

    The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study.

    CLINICAL INFECTIOUS DISEASES . 64(12): 1742-1752. Nº de citas: 98

    [doi:10.1093/cid/cix227]

  • Masiá M, Padilla S, Fernández M, Barber X, Moreno S, Iribarren JA, Portilla J, Peña A, Vidal F, Gutiérrez F, CoRIS.

    Contribution of Oxidative Stress to Non-AIDS Events in HIV-Infected Patients.

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 75(2): . Nº de citas: 11

    [doi:10.1097/QAI.0000000000001287]

  • Moreno S, Antela A, García F, Del Amo J, Boix V, Coll P, Fortuny C, Sirvent JL, Gutiérrez F, Iribarren JA, Llibre JM, Quirós JC, Losa JE, Lozano A, Meulbroek M, Olalla J, Pujol F, Pulido F, Crespo Casal M, García JG, Aldeguer JL, Molina JA, Podzamczer Palter D, Román AR, Grupo Redactor de GESIDA/SEIMC.

    Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(6): 377-383. Nº de citas: 9

    [doi:10.1016/j.eimc.2016.11.016]

  • Muñoz P, Vena A, Padilla B, Valerio M, Sanchez MI, Puig-Asensio M, Fortún J, Fernández-Ruiz M, Merino P, Losa JE, Loza A, Rivas RA, Bouza E, CANDIPOP Project, GEIH-GEMICOMED (SEIMC), and REIPI.

    No evidence of increased ocular involvement in candidemic patients initially treated with echinocandins.

    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE . 88(2): 141-144. Nº de citas: 25

    [doi:10.1016/j.diagmicrobio.2017.02.014]

  • Caniglia EC, Cain LE, Sabin CA, Robins JM, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage GR, Bonnet F, Dabis F, Moore RD, Reiss P, van Sighem A, Mathews WC, Del Amo J, Moreno S, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Napravnik S, Jose S, Phillips A, Justice AC, Tate JP, Gill J, Pacheco A, Veloso VG, Bucher HC, Egger M, Furrer H, Porter K, Touloumi G, Crane H, Miro JM, Sterne JA, Costagliola D, Saag M, Hernán MA, HIV-CAUSAL Collaboration, Centers for AIDS Research Network of Integrated Clinical Systems.

    Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.

    LANCET HIV . 4(6): . Nº de citas: 11

    [doi:10.1016/S2352-3018(17)30043-7]

  • Castón JJ, Lacort I, Martín-Dávila P, Loeches B, Tabares S, Temkin L, Torre-Cisneros J, Paño JR.

    Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients.

    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES . 59: 118-123. Nº de citas: 123

    [doi:10.1016/j.ijid.2017.03.021]

  • González-García A, Fortún J, Elorza Navas E, Martín-Dávila P, Tato M, Gómez-Mampaso E, Moreno S.

    The changing epidemiology of tuberculosis in a Spanish tertiary hospital (1995-2013).

    Medicine . 96(26): . Nº de citas: 11

    [doi:10.1097/MD.0000000000007219]

  • Ortiz-Flores A, Gioia F, Montánez-Fernández L, Santacruz E, Martín-Dávila P, Pian-Arias H, Botella-Carretero JI.

    Incidental finding of a primary thyroid tuberculosis.

    Oxford Medical Case Reports . 2017(6): . Nº de citas: 3

    [doi:10.1093/omcr/omx022]

  • López-Huertas MR, Jiménez-Tormo L, Madrid-Elena N, Gutiérrez C, Rodríguez-Mora S, Coiras M, Alcamí J, Moreno S.

    The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1.

    SCIENTIFIC REPORTS . 7(1): 2385-2385. Nº de citas: 44

    [doi:10.1038/s41598-017-02634-y]

  • de Cueto M, Aliaga L, Alós JI, Canut A, Los-Arcos I, Martínez JA, Mensa J, Pintado V, Rodriguez-Pardo D, Yuste JR, Pigrau C.

    Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(5): 314-320. Nº de citas: 92

    [doi:10.1016/j.eimc.2016.11.005]

  • Brañas F, Jiménez Z, Sánchez-Conde M, Dronda F, López-Bernaldo De Quirós JC, Pérez-Elías MJ, Miralles P, Ramírez M, Moreno A, Berenguer J, Moreno S.

    Frailty and physical function in older HIV-infected adults.

    AGE AND AGEING . 46(3): 522-526. Nº de citas: 57

    [doi:10.1093/ageing/afx013]